WELCOME TO The PHARMACEUTICAL REPORT
Pharmaceutical Sales Strategies Post-COVID-19: The Benefits of Virtual Engagement
April 7, 2021
I'm For Real
Enter your details once to access all our information and resources
Unmatched Experience with Semi-solid and Liquid Formulations
At Dow we focus only on semi-solid and liquid product development, so you know your product is in very experienced hands. After 35+ years.
whitePaper | November 25, 2019
It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers.
whitePaper | April 16, 2020
Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing unexpected cost increases for payers and consumers, and spurring an investigation by the United States Congress. High generic drug prices have had an adverse effect on almost everyone in the pharmaceutical supply chain. Consumers face higher co-pays and prices and health plans are dealing with higher drug spend. Physicians are finding the need to prescribe alternative drug therapies while dealing with angry patients.
whitePaper | January 12, 2020
Supply chains grow more and more complex every day. In response, manufacturers and shippers have been eagerly exploring digital tools that provide actionable insight into the location and condition of in-transit goods. Although there are many technology options when it comes to building a digital supply chain, one type of solution stands out as the most reliable and cost-effective: cellular.
whitePaper | February 11, 2021
Welcome to Pharmaprojects’ 2021 review of trends
in pharmaceutical R&D. For almost 30 years now,
I’ve been taking an annual look at the evolution
of pharma R&D, and in this article I’ll examine
the state of play at the start of 2021.
whitePaper | January 3, 2022
There are many factors that can prevent a patient from being able to obtain the medicine they need, ranging from selective marketing decisions by companies to products being too expensive or pharmacy stock-outs
whitePaper | February 5, 2022
Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains
ensure that the right amount of medicine, with acceptable quality, will reach the customers in need
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE